We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04642469
Brief Title: Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy. (MERMAID-2)

First Submitted : November 3, 2020
First Submitted that Met QC Criteria : November 20, 2020
First Posted : November 24, 2020

Last Update Submitted that Met QC Criteria : August 4, 2022
Last Update Posted : August 5, 2022